K

Active Director Director DIN 09762152
DIN 09762152 First appointment Oct 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value •••• Premium profile

About Kahkasha

Data last updated:

Kahkasha is a Director at Bioangle Pharma Private Limited (since 2022). The company operates in Trading. Bioangle Pharma Private Limited reported revenue of ₹19.8 Lakh (FY 2025).

DIN 09762152
Primary Designation Director
Industry Trading
First Appointment 11 Oct 2022
Oldest Company Age 4 yrs
Largest company Bioangle Pharma Private Limited · ₹19.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bioangle Pharma Private Limited U51909PN2022PTC215388
Director11 Oct 20222022₹19.8 Lakh (FY 2025)Active

Board colleagues of Kahkasha

NameDINCompanyDesignation
Rukhsana Shahzad09762233Bioangle Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bioangle Pharma Private Limited
Premium access

Shareholding and investment profile for Kahkasha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kahkasha

Kahkasha currently holds 1 directorship: Bioangle Pharma Private Limited (Director, since 11 Oct 2022, revenue ₹19.8 Lakh (FY 2025)).

Kahkasha was first appointed on 11 Oct 2022 as Director at Bioangle Pharma Private Limited.

The current boards of Kahkasha's companies include Rukhsana Shahzad (Bioangle Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available